India Inc's July-Sep revenue growth seen at 16-quarter low of 5-7%
Crisil says it is due to stagnant performance in the construction vertical, which accounts for a fifth of India Inc's revenue.
Crisil says it is due to stagnant performance in the construction vertical, which accounts for a fifth of India Inc's revenue.
The pharma company has acquired 100% stake in Bharat Serums and Vaccines Ltd (BSV), which will be funded through a combination of internal accruals and external debt.
Biocon, Dr Reddy’s and Mankind Pharma stress on development and manufacturing of biological drugs, look to cash in on a growing market.
The CCI has cleared Mankind Pharma's proposed acquisition of 100% stake in Bharat Serums and Vaccines for ₹13,630 crore.
The pharma major has transferred its Over-the-Counter (OTC) business to its subsidiary, Mankind Consumer Products, via a slump sale.
Diversified remains the largest contributor to the wealth of India’s richest in 2024, accounting for 36.1% of total wealth.
Shares of Dr. Reddy's Laboratories have risen 36% against its 52-week low of ₹5,212.10 touched on October 30, 2023.
Lupin deals in branded and generic formulations, active pharmaceutical ingredients (APIs), and biosimilars.
The pharma company's revenue for the April-June quarter rose by 5.9% to ₹12,652.75 crore
The revenue from domestic business grew 9% YoY to ₹2,634 cr in Q1 FY25, while exports rose 62% YoY to ₹259 cr